Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vaxart Inc. (VXRT)

0.3499   0.002 (0.6%) 11-11 15:57
Open: 0.35 Pre. Close: 0.3478
High: 0.35 Low: 0.33
Volume: 113,105 Market Cap: 13M
Vaxart Inc, formerly known as Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.351 - 0.352 0.352 - 0.354
Low: 0.326 - 0.328 0.328 - 0.329
Close: 0.347 - 0.35 0.35 - 0.353

Technical analysis

as of: 2019-11-11 4:36:58 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 0.46     One year: 0.53
Support: Support1: 0.33    Support2: 0.30
Resistance: Resistance1: 0.39    Resistance2: 0.46
Pivot: 0.33
Moving Average: MA(5): 0.34     MA(20): 0.34
MA(100): 0.56     MA(250): 1.23
MACD: MACD(12,26): -0.02     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 57.10     %D(3): 53.14
RSI: RSI(14): 45.88
52-week: High: 5.00  Low: 0.25  Change(%): -86.1
Average Vol(K): 3-Month: 69196  10-Days: 17480

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
VXRT has closed below upper band by 16.2%. Bollinger Bands are 65.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to VXRT's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 12 Sep 2019 19:51:47 +0000
Health Care Sector Update for 09/12/2019: VXRT,PDLI,ACB,CPRX

Tue, 09 Apr 2019 18:52:15 +0000
Mid-Afternoon Market Update: Dow Down Over 200 Points; Precipio Shares Spike Higher

Tue, 09 Apr 2019 14:10:18 +0000
Mid-Morning Market Update: Markets Open Lower; PhaseBio Gets Breakthrough Therapy Designation For PB2452

Mon, 15 Apr 2019 14:39:42 +0000
Monday 4/15 Insider Buying Report: VXRT, MHI

Tue, 09 Apr 2019 19:47:27 +0000
Health Care Sector Update for 04/09/2019: CERN,PHAS,CMRX,NVS,VXRT

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38.35
Shares Float (M) 3.91
% Held by Insiders 4.13
% Held by Institutions 40.21
Shares Short (K) 215
Shares Short P. Month (K)

Stock Financials

EPS -2.033
Book Value (p.s.)
PEG Ratio
Profit Margin -244.38
Operating Margin -194.32
Return on Assets (ttm) -21.5
Return on Equity (ttm) -96.5
Qtrly Rev. Growth -86.0
Gross Profit (p.s.) -0.342
Sales Per Share
EBITDA (p.s.) -0.281
Qtrly Earnings Growth
Operating Cash Flow (M) -16.03
Levered Free Cash Flow (M) -8.32

Stock Valuations

P/E -0.17
P/E Growth Ratio
P/BV 0.35
P/S 0.42
P/CF -0.84

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2012-11-09
Forward Dividend
Last Split Date 2018-02-14
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.